Vascular protection by estrogen in ischemia-reperfusion injury requires endothelial nitric oxide synthase

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 1 53-1, 2003, Pages

  Prorock, Alyson J ^a   Hafezi Moghadam, Ali ^b   Laubach, Victor E ^a   Liao, James K ^b   Ley, Klaus ^a,c  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Hlth System Dept of Biomed Eng   (United States)

Author keywords

Inflammation; Leukocyte adhesion; Microcirculation; P selectin; Rolling

Indexed keywords

ESTROGEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PADGEM PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREMASTER MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE WALL; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ADHERENCE; MALE; MICROCIRCULATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SHEAR RATE; STATISTICAL ANALYSIS;

EID: 0037232751     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00957.2001     Document Type: Article

References (50)

1. Armstead VE, Minchenko AG, Schuhl RA, Hayward R, Nossuli TO, and Lefer AM. Regulation of P-selectin expression in human endothelial cells by nitric oxide. Am J Physiol Heart Circ Physiol 273: H740-H746, 1997.
2. Auger KR, Serunian LA, Soltoff SP, Libby P, and Cantley LC. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 57: 167-175, 1989.
3. Baez S. An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc Res 5: 384-394, 1973.
4. Bolanos JP, and Almeida A. Roles of nitric oxide in brain hypoxia-ischemia. Biochim Biophys Acta 1411: 415-436, 1999.
5. Burgering BM, and Coffer PJ. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599-602, 1995.
6. Davenpeck KL, Gauthier TW, and Lefer AM. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 107: 1050-1058, 1994.
7. De Graaf JC, Banga JD, Moncada S, Palmer RM, de Groot PG, and Sixma JJ. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 85: 2284-2290, 1992.
8. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, and Dedhar S. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 95: 11211-11216, 1998.
9. Entman ML, and Smith CW. Postreperfusion inflammation: A model for reaction to injury in cardiovascular disease. Cardiovasc Res 28: 1301-1311, 1994.
10. Eppihimer MJ, Russell J, Anderson DC, Epstein CJ, Laroux S, and Granger DN. Modulation of P-selectin expression in the postischemic intestinal microvasculature. Am J Physiol Gastrointest Liver Physiol 273: G1326-G1332, 1997.
11. Franke TF, Kaplan DR, and Cantley LC. PI3K P13K: Downstream AKTion blocks apoptosis. Cell 88: 435-437, 1997.
12. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, and Tsichlis PN. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727-736, 1995.
13. Freedman JE, Sauter R, Battinelli EM, Ault K, Knowles C, Huang PL, and Loscalzo J. Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene. Circ Res 84: 1416-1421, 1999.
14. Furchgott RF, and Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 3: 2007-2018, 1989.
15. Gaboury J, Woodman RC, Granger DN, Reinhardt P, and Kubes P. Nitric oxide prevents leukocyte adherence: role of superoxide. Am J Physiol Heart Circ Physiol 265: H862-H867, 1993.
16. Gauthier TW, Davenpeck KL, and Lefer AM. Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 267: G562-G568, 1994.
17. Gauthier TW, Scalia R, Murohara T, Guo JP, and Lefer AM. Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. Arterioscler Thromb 15: 1652-1659, 1995.
18. Hafezi-Moghadam A, Simoncini T, Yang Limbourg FP, Plumier JC, Rebsamen MC, Hsieh CM, Chui DS, Thomas KL, Prorock AJ, Laubach VE, Moskowitz MA, French BA, Ley K, and Liao JK. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 8: 473-479, 2002.
19. Hearse DJ, Maxwell L, Saldanha C, and Gavin JB. The myocardial vasculature during ischemia and reperfusion: A target for injury and protection. J Mol Cell Cardiol 25: 759-800, 1993.
20. Hickey MJ. Role of inducible nitric oxide synthase in the regulation of leucocyte recruitment. Clin Sci (Colch) 100: 1-12, 2001.
21. Hogaboam CM, Donigi-Gale D, Shoupe TS, Bissonnette EY, Befus AD, and Wallace JL. Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds. Br J Pharmacol 105: 87-92, 1992.
22. Horie Y, Wolf R, Anderson DC, and Granger DN. Nitric oxide modulates gut ischemia-reperfusion-induced P-selectin expression in murine liver. Am J Physiol Heart Circ Physiol 275: H520-H526, 1998.
23. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, and Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377:239-242, 1995.
24. Jeroudi MO, Hartley CJ, and Bolli R. Myocardial reperfusion injury: Role of oxygen radicals and potential therapy with antioxidants. Am J Cardiol 73: 2B-7B, 1994.
25. Jones SP, Girod WG, Palazzo AJ, Granger DN, Grisham MB, Jourd'Heuil D, Huang PL, and Lefer DJ. Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am J Physiol Heart Circ Physiol 276: H1567-H1573, 1999.
26. Jung U, and Ley K. Regulation of E-selectin, P-selectin, and intercellular adhesion molecule 1 expression in mouse cremaster muscle vasculature. Microcirculation 4: 311-319, 1997.
27. Jung U, Norman KE, Scharffetter-Kochanek K, Beaudet AL, and Ley K. Transit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivo. J Clin Invest 102: 1526-1533, 1998.
28. Kanwar S, Smith CW, and Kubes P. An absolute requirement for P-selectin in ischemia/reperfusion-induced leukocyte recruitment in cremaster muscle. Microcirculation 5: 281-287, 1998.
29. Kloner RA, Przyklenk K, and Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation 80: 1115-1127, 1989.
30. Kubes P, Kurose I, and Granger DN. NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. Am J Physiol Heart Circ Physiol 267: H931-H937, 1994.
31. Kubes P, Suzuki M, and Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651-4655, 1991.
32. Kunkel EJ, Dunne JL, and Ley K. Leukocyte arrest during cytokine-dependent inflammation in vivo. J Immunol 164: 3301-3308, 2000.
33. Lefer DJ, Jones SP, Girod WG, Baines A, Grisham MB, Cockrell AS, Huang PL, and Scalia R. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol Heart Circ Physiol 276: H1943-H1950, 1999.
34. Lipowsky HH, and Zweifach BW. Application of the "two-slit" photometric technique to the measurement of microvascular volumetric flow rates. Microvasc Res 15: 93-101, 1978.
35. Michel T, and Feron O. Nitric oxide synthases: Which, where, how, and why? J Clin Invest 100: 2146-2152, 1997.
36. Moncada S, Palmer RM, and Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
37. Murohara T, Parkinson SJ, Waldman SA, and Lefer AM. Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets. Role of protein kinase C. Arterioscler Thromb 15: 2068-2075, 1995.
38. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051-3064, 1992.
39. Rameh LE, and Cantley LC. The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem 274: 8347-8350, 1999.
40. Rees DD, Palmer RM, Schulz R, Hodson HF, and Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101: 746-752, 1990.
41. Reneman Woldhuis RB, oude Egbrink M, Slaaf D, and Tangelder G. Concentration and velocity profiles of blood cells in the microcirculation. In: Advances in Cardiovascular Engineering, edited by Hwang N, Turitto V and Yen M. New York: Plenum, 1993, p. 25-40.
42. Samdani AF, Dawson TM, and Dawson VL. Nitric oxide synthase in models of focal ischemia. Stroke 28: 1283-1288, 1997.
43. Scalia R, Gauthier TW, Murohara T, and Lefer AM. Oligotide attenuates leukocyte-endothelial cell interaction via P-selectin in the rat mesenteric vascular bed. Eur J Pharmacol 296: 181-187, 1996.
44. Scalia R, Kochilas L, Campbell B, and Lefer AM. Effects of defibrotide on leukocyte-endothelial cell interaction in the rat mesenteric vascular bed: Role of P-selectin. Methods Find Exp Clin Pharmacol 18: 669-676, 1996.
45. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, and Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 93: 13176-13181, 1996.
46. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, and Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407: 538-541, 2000.
47. Smith CW. Endothelial adhesion molecules and their role in inflammation. Can J Physiol Pharmacol 71: 76-87, 1993.
48. Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB, Gaffney PR, Reese CB, McCormick F, Tempst P, Coadwell J, and Hawkins PT. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279: 710-714, 1998.
49. Sullivan GW, Sarembock IJ, and Linden J. The role of inflammation in vascular diseases. J Leukoc Biol 67: 591-602, 2000.
50. Zimmerman GA, McIntyre TM, Mehra M, and Prescott SM. Endothelial cell-associated platelet-activating factor: A novel mechanism for signaling intercellular adhesion. J Cell Biol 110: 529-540, 1990.